home / stock / dbv / dbv news


DBV News and Press, Invesco DB G10 Currency Harvest Fund

Stock Information

Company Name: Invesco DB G10 Currency Harvest Fund
Stock Symbol: DBV
Market: NYSE

Menu

DBV DBV Quote DBV Short DBV News DBV Articles DBV Message Board
Get DBV Alerts

News, Short Squeeze, Breakout and More Instantly...

DBV - Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024

Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 ...

DBV - DBV Technologies Announces Filing of 2024 Half-Year Report - Conditions for Accessing or Consulting the Report

Châtillon, France, July 30, 2024 DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutic...

DBV - DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results

Châtillon, France, July 30, 2024 DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results VITESSE enrollment in peanut allergic 4-7-year-olds is on-track and recruitment is expecte...

DBV - DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024

Châtillon, France, July 29, 2024 DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, toda...

DBV - DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Châtillon, France, June 5, 2024 DBV Technologies to Participate in the Goldman Sachs 45 th Annual Global Healthcare Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical compa...

DBV - Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024

Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 *...

DBV - DBV Technologies to Participate in Upcoming EAACI 2024 Congress

Châtillon, France, May 30, 2024 DBV Technologies to Participate in Upcoming EAACI 2024 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food alle...

DBV - DBV Technologies Announces Plan to Implement ADS Ratio Change

Châtillon, France, May 17, 2024 DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT—CUSIP: 23306J101), a clinical-stage biopharmaceutical company focused on treatment o...

DBV - DBV Technologies Announces Results of its 2024 Combined General Meeting

Châtillon, France, May 16, 2024 DBV Technologies Announces Results of its 2024 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “ Company ...

DBV - DBV Technologies to Participate in Upcoming Investor Conferences

Montrouge, France, May 9, 2024 DBV Technologies to Participate in Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergi...

Next 10